Research Highlight Published: Drug repurposing Nature Mental Health volume 3 , page 274 (2025) Cite this article 245 Accesses 1 Citations Metrics details A recent phase 2 randomized controlled trial by Hendershot et al
The titration was gentle barely any nausea past week 2 and the care team checks in proactively without me chasing them. Sarah K
The use of a dulaglutide, a GLP-1, led to a 14 percent reduction in diagnosis of cognitive dysfunction reported in patients with type 2 diabetes in the REWIND trial [funded by Eli Lilly]
Tracking: you keep simple records of dose, side effects, hunger, and weightthis is the backbone of any safe microdosing guide
Patients are encouraged to seek medical advice promptly if they experience any unusual symptoms, and to consistently monitor their body weight compared to maximizing the benefits of this injectable prescription medicine
Our team of experts will assess your health and weight loss goals to determine if compounded Tirzepatide is the right option for you and create a personalized treatment plan to support your success
